Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells
about
Diet-Induced Obesity Is Associated with an Impaired NK Cell Function and an Increased Colon Cancer IncidenceChimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityGene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele.Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor.Automated enrichment, transduction and expansion of clinical-scale CD62L+ T cells for manufacturing of GTMPs.Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function.Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation.Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model.Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition.A TCR-based Chimeric Antigen Receptor.A potent human neutralizing antibody Fc-dependently reduces established HBV infectionsMolecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies.Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines.Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway.A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy.Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia.Human Pluripotent Stem Cells to Produce Cell-based Cancer Immunotherapy.Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers.Sestrin2 and sestrin3 suppress NK-92 cell-mediated cytotoxic activity on ovarian cancer cells through AMPK and mTORC1 signaling.A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma.Immunotherapy for Dogs: Running Behind Humans.NK-92 cell, another ideal carrier for chimeric antigen receptor.Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma.Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.Immunotherapy for Gastric Cancer: Time for a Personalized Approach?Immuno-Oncology: Emerging Targets and Combination TherapiesPositive & Negative Roles of Innate Effector Cells in Controlling Cancer ProgressionViral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer ImmunotherapiesNatural Killer Cells: Development, Maturation, and Clinical Utilization
P2860
Q30313294-A6FEB038-326F-4D42-A8D8-953F3CE501C2Q33700795-2AC7DF8E-E6C2-49B5-BCFF-BEED964945E5Q33913839-2F2D7D85-F175-47FB-BD27-68E3153CF738Q37686302-DFAF4200-5547-4714-99C8-58EC8218D461Q38634034-144F2D53-C9D3-4CCA-B071-E967CD74D63EQ38670431-BF6D1291-2AC5-474F-BBA6-C1B570D1CAB8Q38685785-E79F75F0-0106-4614-A446-8A17F30219A2Q38694652-A29609FB-1D41-4C9F-9811-0AEB2A375344Q38704554-9E9AC8F2-1ADA-43B2-878B-2011E2330378Q38722015-B8E3F82B-3C76-4249-ABE4-6A75DBECC84CQ38827775-D06AD7B2-9F19-46B5-8000-B2162283BB51Q38915262-F6EBAF5D-D755-4592-AEA6-4D4F2B213D4DQ39296861-01315E82-3F31-4470-85E5-08E6B5379A40Q41074467-DD6A1C6F-3E24-46FB-81AD-96EC37C242BBQ41367801-0D36610F-1429-4F29-8D1B-DB4694EB477BQ41631133-952E8485-E383-45BB-B08B-D4744AC86538Q41671765-BE682997-453E-485C-83F5-AEA148ABBF6DQ41684107-ACE97AA1-C994-4823-972E-25F7B7254E51Q42015845-8B711F20-303D-4B6B-ADCC-59CD5B64ABF5Q44243898-3C483858-3558-4B06-A922-902EED241A53Q45119837-73A02B1C-14D7-4DD6-B330-F6E64AF58BF1Q46046777-0C8E395D-E546-4A44-B72D-11C75AA6E4C9Q46279219-2CDCFC50-C1F2-49BF-A86A-43600B9429A8Q46350666-E38ADF6B-A11E-4030-BA14-28A1006FB0C3Q46366459-375D9F6C-F669-40EB-9C55-175681ABBE28Q47113878-FDF446AA-CA32-4765-8657-B68D30DF9E01Q48169701-41B8F6D0-AAB5-4226-B715-30B3BA2FF857Q49237902-78D188CD-5278-4650-8956-D0E342B307D0Q49829334-AE17C808-CBEA-4B79-AB61-480CEB11DC22Q50027824-C47F209C-3B1F-47CD-9998-E3AB77BFA4A2Q52615722-CDC5E1E4-C50A-472B-A3D0-3081F87DEE36Q52680552-39B8674F-2424-4E7C-8364-78FD7B8D3DD3Q55008640-7D91FB13-2A13-4CF4-AD77-B774762D77A9Q55024747-B49A435B-58FE-45F7-9B17-9E9058E9199DQ55493323-AC5DFA85-001C-411C-93CB-32E33E6F82EFQ55652343-2BCDAA9A-4DC8-4183-BC00-E5F8A29244A4Q56889817-FC72DECD-DBEF-4A9F-B169-BE7B09982671Q57300020-03763742-D6A4-4EB8-B1F2-83ED6E9D642EQ57300237-E97E2E54-80CC-4C17-8A8F-E427B022A156Q58785734-C14012DA-D98F-4807-9861-86952B2A65E9
P2860
Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@ast
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@en
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@nl
type
label
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@ast
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@en
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@nl
prefLabel
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@ast
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@en
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@nl
P2093
P2860
P3181
P356
P1476
Natural Killer Cells for Immun ...... Cell Line over Blood NK Cells
@en
P2093
Frances Toneguzzo
Hans Klingemann
Laurent Boissel
P2860
P3181
P356
10.3389/FIMMU.2016.00091
P407
P577
2016-01-01T00:00:00Z